Difference between revisions of "Part:BBa K864000"
m
 
Line 5: Line 5:
  
 
===Usage and Biology===
 
===Usage and Biology===
−
This part is available as pSB4A15-[[Part:BBa_K864121|pUCori-red]].  This facilitates high plasmid yields and fast red color expression on transformation plates.  
+
This part is available as pSB4A15-[[Part:BBa_K864120|pUCori-red]].  This facilitates high plasmid yields and fast red color expression on transformation plates.  
  
 
<!-- -->
 
<!-- -->

Latest revision as of 19:17, 27 September 2012

Low copy BioBrick standard vector

pSB4A15 is a BioBrick standard vector with low copy pSC101 replication origin BBa_K864050 (~5 copies per cell) and ampicillin antibiotic resistance marker, especially usable for Lambda Red recombineering in E coli. The backbone sequence is based on pSB3T5, but the E coli His operon terminator BBa_B0053 has been replaced with the late terminator of the Salmonella phage P22.

Usage and Biology

This part is available as pSB4A15-pUCori-red. This facilitates high plasmid yields and fast red color expression on transformation plates.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Plasmid lacks a prefix.
    Plasmid lacks a suffix.
    Illegal EcoRI site found at 3618
    Illegal NheI site found at 2425
    Illegal SpeI site found at 2
    Illegal PstI site found at 16
    Illegal NotI site found at 9
    Illegal NotI site found at 3624
  • 21
    INCOMPATIBLE WITH RFC[21]
    Plasmid lacks a prefix.
    Plasmid lacks a suffix.
    Illegal EcoRI site found at 3618
  • 23
    INCOMPATIBLE WITH RFC[23]
    Illegal prefix found at 3618
    Illegal suffix found at 2
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal prefix found at 3618
    Plasmid lacks a suffix.
    Illegal XbaI site found at 3633
    Illegal SpeI site found at 2
    Illegal PstI site found at 16
    Illegal NgoMIV site found at 2319
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Plasmid lacks a prefix.
    Plasmid lacks a suffix.